Unadjusted and adjusted HRs for survival and PFS for patients with relapsed FL receiving either HD-RIT or C-HDT and ASCT
Endpoint . | Unadjusted hazard ratio (95% CI) . | P . | Adjusted hazard ratio (95% CI)* . | P . |
|---|---|---|---|---|
| Death | ||||
| C-HDT | 1 | 1 | ||
| HD-RIT | 0.4 (0.2-0.9) | .02 | 0.3(0.1-0.7) | .004 |
| Progression or death | ||||
| C-HDT | 1 | 1 | ||
| HD-RIT | 0.6(0.3-1.0) | .06 | 0.5 (0.3-0.9) | .03 |
Endpoint . | Unadjusted hazard ratio (95% CI) . | P . | Adjusted hazard ratio (95% CI)* . | P . |
|---|---|---|---|---|
| Death | ||||
| C-HDT | 1 | 1 | ||
| HD-RIT | 0.4 (0.2-0.9) | .02 | 0.3(0.1-0.7) | .004 |
| Progression or death | ||||
| C-HDT | 1 | 1 | ||
| HD-RIT | 0.6(0.3-1.0) | .06 | 0.5 (0.3-0.9) | .03 |
Hazard ratio was adjusted for elevated LDH, presence of transformed disease, and IPI score.